We are live on
!
Find out more
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
46 hedge funds and large institutions have $7.06M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 24 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
8,833% more call options, than puts
Call options by funds: $536K | Put options by funds: $6K
52% less funds holding
Funds holding: 95 → 46 (-49)
54% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 24
75% less capital invested
Capital invested by funds: $27.9M → $7.06M (-$20.8M)
96% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 50
Holders
46
Holders Change
-49
Holders Change %
-51.58%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
11
Reduced
24
Closed
50
Calls
$536K
Puts
$6K
Net Calls
+$530K
Net Calls Change
+$457K
Top Buyers
| 1 |
Millennium Management
New York
|
+$268K |
| 2 |
Morgan Stanley
New York
|
+$206K |
| 3 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$120K |
| 4 |
Jane Street
New York
|
+$34.7K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$18K |
Top Sellers
| 1 |
PA
Perceptive Advisors
New York
|
-$1.1M |
| 2 |
BlackRock
New York
|
-$949K |
| 3 |
State Street
Boston,
Massachusetts
|
-$304K |
| 4 |
Renaissance Technologies
New York
|
-$242K |
| 5 |
Bank of New York Mellon
New York
|
-$215K |
